Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
301017.SZ
HOLDGet insider-trade alertsShuYu Civilian Pharmacy Corp., Ltd. · Healthcare · China · $783M · Avg Vol: $16M/d
COMPANY DESCRIPTION
ShuYu Civilian Pharmacy Corp., Ltd. operates a large-scale retail pharmacy chain in China, offering prescription drugs, OTC medicines, and healthcare products. The company holds a dominant market position in Shandong province and is aggressively expanding its national footprint through a dual direct-sales and franchise model. Its competitive advantage is driven by its strong regional brand equity, advanced digital O2O (online-to-offline) pharmacy services, and centralized procurement scale.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1.2B | 1.4B | 1.4B | 1.5B | 9.7% | 1.6B |
| EPS | 0.08 | 0.05 | -0.07 | 0.04 | -21.1% | 0.04 |
| Shares | 405.3M | 405.3M | 405.4M | 405.4M | +0.0% | 405.6M |
| Debt | 436.0M | 570.4M | 585.9M | 452.0M | 1.2% | 506.0M |
| Equity | 328.6M | 337.6M | 300.5M | 313.8M | -1.5% | — |
| Op CF | 21.9M | 21.0M | 72.1M | 118.3M | 75.5% | 113.3M |
| Inv CF | -42.0M | -142.2M | -33.8M | -96.4M | — | — |
| Fin CF | 194.7M | 20.9M | -40.8M | -83.3M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 301017.SZ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 301017.SZ | ShuYu Civilian Pharmacy Corp., Ltd.(you) | $783M | 41 | HOLD |
| 002788.SZ | Luyan Pharma Co.,Ltd. | $575M | 53 | HOLD |
| 301408.SZ | Anhui Huaren Health Pharmaceutical Co., Ltd. | $835M | 72 | BUY |
| 6086.HK | Fangzhou Inc. | $124M | 32 | SELL |
| 9885.HK | YSB Inc. | $356M | 77 | BUY |
| 002727.SZ | Yixintang Pharmaceutical Group Co., Ltd. | $852M | 95 | STRONG BUY |
| 603883.SS | LBX Pharmacy Chain Joint Stock Company | $1.2B | 93 | STRONG BUY |
| 603233.SS | DaShenLin Pharmaceutical Group Co., Ltd. | $2.5B | 99 | STRONG BUY |
| 603939.SS | Yifeng Pharmacy Chain Co., Ltd. | $3.2B | 98 | STRONG BUY |
| 6618.HK | JD Health International Inc. | $13.0B | 84 | STRONG BUY |
Peer medians: ROE 4.8% · P/E 26.5x · Gross margin 52.5%